Concepedia

Author

Michael Imboden

University of Wisconsin–Madison

Also Known As

M Imboden, Michael Imboden, Michael. Imboden

15

Publications

509

Citations

10

H-Index

38

Concepts

All Affiliations

University of Wisconsin–MadisonUniversity of ArizonaioGenetics (United States)Scripps Research Institute
MI

About

Michael Imboden is an author at University of Wisconsin–Madison specializing in immunology, medicine, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

232

2

Immunology

6

6

232

3

Cell Biology

2

2

98

4

Education

1

1

20

5

Allergy

1

1

29

Michael Imboden

×

10

Publications

506

Citations

10

H-Index

YearCitations

Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells

Joel G. Turner, Alexander L. Rakhmilevich, Lyudmila G. Burdelya,

The Journal of Immunology

2001

103

Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

Zane C. Neal, Jeannie C. Yang, Alexander L. Rakhmilevich,

Clinical Cancer Research

2004

93

Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa

Sujun Li, Shyamtanu Datta, Emily Brabbit,

Gene Therapy

2020

61

Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.

Alexander L. Rakhmilevich, Michael Imboden, Zhengling Hao,

PubMed

2001

51

NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy

Zane C. Neal, Michael Imboden, Alexander L. Rakhmilevich,

Cancer Immunology Immunotherapy

2003

48

The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.

Michael Imboden, K R Murphy, Alexander L. Rakhmilevich,

PubMed

2001

47

Phospholipases and Cationic Peptides Inhibit Cryptosporidium parvum Sporozoite Infectivity by Parasiticidal and Non-Parasiticidal Mechanisms

Stéphane Carryn, Deborah A. Schaefer, Michael Imboden,

Journal of Parasitology

2012

37

Safety of Interleukin-12 Gene Therapy Against Cancer: A Murine Biodistribution and Toxicity Study

Michael Imboden, Fushun Shi, Thomas D. Pugh,

Human Gene Therapy

2003

29

Antibody fusions reduce onset of experimental Cryptosporidium parvum infection in calves

Michael Imboden, Deborah A. Schaefer, Robert D. Bremel,

Veterinary Parasitology

2012

20

Antibodies Fused to Innate Immune Molecules Reduce Initiation of<i>Cryptosporidium parvum</i>Infection in Mice

Michael Imboden, Michael W. Riggs, Deborah A. Schaefer,

Antimicrobial Agents and Chemotherapy

2010

17

Page 1